Browse by author
Lookup NU author(s): Dr Diarmuid CoughlanORCiD
This is the authors' accepted manuscript of an article that has been published in its final definitive form by Oxford University Press, 2020.
For re-use rights please refer to the publisher's terms and conditions.
Medical care costing studies have excluded patients with a prior cancer history. This study aims to update methods for estimating medical care costs attributable to cancer and to evaluate the effect of a prior history of cancer on costs for colorectal cancer (CRC) patients. We used Surveillance, Epidemiology, and End Results (SEER)-Medicare data and matched cancer patients to controls without cancer to estimate cancer-attributable costs by phases of care using Medicare 2007–2013 claims. CRC annualized average cancer-attributable costs were $56.0 K, $5.3 K, $92.5 K, and $24.3 K in the initial, continuing, and end-of-life cancer and noncancer death phases, respectively, in 2014 dollars. Costs were higher for patients diagnosed with more advanced stage, younger ages, and nonwhite races. Costs for patients with prior cancers were consistently higher than patients without prior cancers, especially in the continuing (4.9 K vs 7.2 K) and end-of-life noncancer death (22.7 K vs 30.0 K). Our CRC costs improve previous estimates by using more recent data and updated methods.
Author(s): Mariotto AB, Warren JL, Zeruto C, Coughlan D, Barrett MJ, Zhao L, Yabroff KR
Publication type: Article
Publication status: Published
Journal: Journal of the National Cancer Institute Monographs
Online publication date: 15/05/2020
Acceptance date: 19/11/2019
Date deposited: 03/06/2020
ISSN (print): 1052-6773
ISSN (electronic): 1745-6614
Publisher: Oxford University Press
PubMed id: 32412066
Altmetrics provided by Altmetric